tiprankstipranks
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
US Market
ANTX
AN2 Therapeutics, Inc.
RESEARCH TOOLSreports

AN2 Therapeutics, Inc. (ANTX) Ownership - Who Owns AN2 Therapeutics, Inc.?

Compare
105 Followers

AN2 Therapeutics, Inc. (ANTX) Ownership Overview

26.54%3.35%11.56%2.74%55.81%
26.54% Insiders
3.35% Mutual Funds
11.56% Other Institutional Investors
2.74% ETFs
55.81% Public Companies and
Individual Investors
The ownership structure of AN2 Therapeutics, Inc. (ANTX) stock is a mix of institutional, retail, and individual investors. Approximately 17.66% of the company’s stock is owned by Institutional Investors, 26.54% is owned by Insiders, and 55.81% is owned by Public Companies and Individual Investors.
The ownership structure of AN2 Therapeutics, Inc. (ANTX) stock is a mix of institutional, retail, and individual investors. Approximately 14.91% of the company’s stock is owned by Institutional Investors, 26.54% is owned by Insiders, and 2.74% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 05, 2026
Sarah Joanne Williams
xxxxxxxxxxxxx
$347
Jan 07, 2026
Stephen David Prior
xxxxxxxxxxxxx
$6491
Jan 07, 2026
Eizen Joshua M
xxxxxxxxxxxxx
$24923
Jun 16, 2025
Braden Michael Leonard
xxxxxxxxxxxxx
$218000
Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2023
Woodline Partners Lp
xxxxxxxxxxxxx
$166407
Show More Hedge Fund Trading Activity >

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,017,432Insider8.40%12,069,728
2,425,979Insider6.75%9,703,916
1,628,512Insider4.53%6,514,048
1,243,938Insider3.46%4,975,752
935,028Institution2.60%3,740,112
935,028Institution2.60%3,740,112
551,418Insider1.53%2,205,672
208,581Institution0.58%834,324
207,499Insider0.58%829,996
Michael Rockefeller
145,971Institution0.41%583,884

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
935,028Institution2.60%3,740,112
208,581Institution0.58%834,324
59,000Institution0.16%236,000
1,347Institution<0.01%5,388

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
Vanguard Total Stock Market ETF
733,392Institution2.04%806,731
Vanguard Extended Market ETF
201,636Institution0.56%221,800
iShares Micro-Cap ETF
49,820Institution0.14%199,280

FAQ

Who Owns AN2 Therapeutics, Inc. (ANTX)?
According to the latest TipRanks data, approximately 11.56% of the company's stock is held by institutional investors, 26.54% is held by insiders, and 55.81% is held by retail investors.
    What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 11.56% of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors.
      What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 55.81% of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors.
        Who owns the most shares of AN2 Therapeutics, Inc. (ANTX)?
        Braden Michael Leonard owns the most shares of AN2 Therapeutics, Inc. (ANTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.